Efficacy and safety of selinexor in the treatment of AML: A protocol for systematic review and meta-analysis

BACKGROUND: Acute myeloid leukemia (AML) is the most common leukemia among the adult population and accounts for about 80% of all cases. Despite advancements in therapeutic regimens, the prognosis remains very poor, especially in the elderly population. Selinexor is a first-in-class, oral, small mol...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Liming, Yin, Xuewei, Si, Yuping, Wang, Yan, Wang, Jingyi, Cui, Siyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663856/
https://www.ncbi.nlm.nih.gov/pubmed/34889237
http://dx.doi.org/10.1097/MD.0000000000027884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663856/
https://www.ncbi.nlm.nih.gov/pubmed/34889237
http://dx.doi.org/10.1097/MD.0000000000027884

Ejemplares similares